These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Studies on the mechanism of action of 6-azauracil. TAKAGI Y; OTSUJI N Biochim Biophys Acta; 1958 Jul; 29(1):227-8. PubMed ID: 13560479 [No Abstract] [Full Text] [Related]
4. [On the inhibition of L-glutamic acid and L-DOPA decarboxylase by D-cycloserine and other isoxazolidones]. DENGLER HJ; RAUCHS E; RUMMEL W Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1962; 243():366-81. PubMed ID: 13885421 [No Abstract] [Full Text] [Related]
5. Effects of decarboxylase inhibition on the biosynthesis of brain monoamines. BRODIE BB; KUNTZMAN R; HIRSCH CW; COSTA E Life Sci (1962); 1962 Mar; 1():81-4. PubMed ID: 13873301 [No Abstract] [Full Text] [Related]
6. Accumulation of nucleic acid metabolites in Escherichia coli exposed to the action of 6-azauracil. SKODA J; SORM F Biochim Biophys Acta; 1958 Jun; 28(3):659-60. PubMed ID: 13560432 [No Abstract] [Full Text] [Related]
7. Inhibition of diaminopimelic acid decarboxylase activity in Mycobacterium tuberculosis by isonicotinic acid hydrazide. WILLETT HP Proc Soc Exp Biol Med; 1958 Oct; 99(1):177-9. PubMed ID: 13601806 [No Abstract] [Full Text] [Related]
8. Monoamine oxidase and decarboxylase inhibitors as antihypertensive agents. GILLESPIE L; SJOERDSMA A Med Clin North Am; 1961 Mar; 45():421-8. PubMed ID: 13705342 [No Abstract] [Full Text] [Related]
9. [Repression of meso-alpha, epsilon-diaminopimelic acid decarboxylase by L-lysine in Escherichia coli]. PATTE JC; LOVINY T; COHEN GN Biochim Biophys Acta; 1962 Apr; 58():359-60. PubMed ID: 14484389 [No Abstract] [Full Text] [Related]
10. Decarboxylase inhibitors in the treatment of hypertension. BREST AN; MOYER JH Am J Cardiol; 1962 Jan; 9():116-9. PubMed ID: 13872878 [No Abstract] [Full Text] [Related]
11. Inhibition of brain glutamic decarboxylase by running fit-inducing substances. NISHIZAWA Y; KODAMA T; YAMANAKA T J Vitaminol (Kyoto); 1959 Jun; 5():111-6. PubMed ID: 14427322 [No Abstract] [Full Text] [Related]
12. Actions of the decarboxylase inhibitor, alpha-methyl-3,4-dihydroxyphenylalanine, in the dog. GOLDBERG LI; DACOSTA FM; OZAKI M Nature; 1960 Nov; 188():502-4. PubMed ID: 13706461 [No Abstract] [Full Text] [Related]
13. Inhibition of leucine decarboxylase by thiol-binding reagents. SUTTON CR; KING HK Arch Biochem Biophys; 1962 Feb; 96():360-70. PubMed ID: 13918558 [No Abstract] [Full Text] [Related]
14. Studies on the pharmacology of 6-azauracil. WELCH AD; HANDSCHUMACHER RE; JAFFE JJ J Pharmacol Exp Ther; 1960 Jul; 129():262-70. PubMed ID: 13843819 [No Abstract] [Full Text] [Related]
15. Effects of a pyrimidine analog, 6-azauracil, on rat electroencephalogram and maze running ability. MORRIS NR; GLASER GH Electroencephalogr Clin Neurophysiol; 1959 Feb; 11(1):146-50. PubMed ID: 13630241 [No Abstract] [Full Text] [Related]
16. Electroencephalographic and neurological changes induced in man by the administration of 1, 2,4-triazine-3,5 (2H, 4H)-dione (6-azauracil). WELLS CE; AJMONE-MARSAN C; FREI E; TUOHY JH; SHNIDER BI Electroencephalogr Clin Neurophysiol; 1957 May; 9(2):325-32. PubMed ID: 13414655 [No Abstract] [Full Text] [Related]
17. Influence of 6-azauracil on the metabolism of Bacillus cereus. SELLS BH Biochem Pharmacol; 1959 Nov; 2():255-63. PubMed ID: 14444759 [No Abstract] [Full Text] [Related]
18. The biosynthesis of 6-azauracil riboside by Escherichia coli growing in the presence of 6-azauracil. SKODA J; HESS VF; SORM F Experientia; 1957 Apr; 13(4):150-1. PubMed ID: 13447904 [No Abstract] [Full Text] [Related]
19. Nature of the inhibition of yeast carboxylase by acetaldehyde. GRUBER M; WESSELIUS JC Biochim Biophys Acta; 1962 Feb; 57():171-3. PubMed ID: 13902366 [No Abstract] [Full Text] [Related]
20. Inhibition of yeast carboxylase by acetaldehyde. GRUBER M; WASSENAAR JS Biochim Biophys Acta; 1960 Feb; 38():355-7. PubMed ID: 13829772 [No Abstract] [Full Text] [Related] [Next] [New Search]